• 1
    American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force. Extremity magnetic resonance imaging in rheumatoid arthritis: report of the American College of Rheumatology Extremity Magnetic Resonance Imaging Task Force [review]. Arthritis Rheum 2006; 54: 103447.
  • 2
    Suzuki T, Ito S, Handa S, Kose K, Okamoto Y, Minami M, et al. A new low-field extremity magnetic resonance imaging and proposed compact MRI score: evaluation of anti-tumor necrosis factor biologics on rheumatoid arthritis. Mod Rheumatol 2009; 19: 35865.
  • 3
    Olech E, Freeston JE, Conaghan PG, Hensor EM, Emery P, Yocum D. Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practice. J Rheumatol 2008; 35: 5803.
  • 4
    Chen TS, Crues JV 3rd, Ali M, Troum OM. Magnetic resonance imaging is more sensitive than radiographs in detecting change in size of erosions in rheumatoid arthritis. J Rheumatol 2006; 33: 195767.
  • 5
    Ejbjerg BJ, Vestergaard A, Jacobsen S, Thomsen H, Ostergaard M. Conventional radiography requires a MRI-estimated bone volume loss of 20% to 30% to allow certain detection of bone erosions in rheumatoid arthritis metacarpophalangeal joints. Arthritis Res Ther 2006; 8: R59.
  • 6
    Freeston JE, Conaghan PG, Dass S, Vital E, Hensor EM, Stewart SP, et al. Does extremity-MRI improve erosion detection in severely damaged joints? A study of long-standing rheumatoid arthritis using three imaging modalities. Ann Rheum Dis 2007; 66: 153840.
  • 7
    Duer-Jensen A, Ejbjerg B, Albrecht-Beste E, Vestergaard A, Dohn UM, Hetland ML, et al. Does low-field dedicated extremity MRI (E-MRI) reliably detect bone erosions in rheumatoid arthritis? A comparison of two different E-MRI units and conventional radiography with high resolution CT scanning. Ann Rheum Dis 2009; 68: 1296302.
  • 8
    Conaghan PG, Ejbjerg B, Lassere M, Bird P, Peterfy C, Emery P, et al. A multicenter reliability study of extremity-magnetic resonance imaging in the longitudinal evaluation of rheumatoid arthritis. J Rheumatol 2007; 34: 8578.
  • 9
    Duer-Jensen A, Vestergaard A, Dohn UM, Ejbjerg B, Hetland ML, Albrecht-Beste E, et al. Detection of rheumatoid arthritis bone erosions by two different dedicated extremity MRI units and conventional radiography. Ann Rheum Dis 2008; 67: 9981003.
  • 10
    Schirmer C, Scheel AK, Althoff CE, Schink T, Eshed I, Lembcke A, et al. Diagnostic quality and scoring of synovitis, tenosynovitis and erosions in low-field MRI of patients with rheumatoid arthritis: a comparison with conventional MRI. Ann Rheum Dis 2007; 66: 5229.
  • 11
    Bird P, Ejbjerg B, Lassere M, Ostergaard M, McQueen F, Peterfy C, et al. A multireader reliability study comparing conventional high-field magnetic resonance imaging with extremity low-field MRI in rheumatoid arthritis. J Rheumatol 2007; 34: 8546.
  • 12
    Eshed I, Althoff CE, Schink T, Scheel AK, Schirmer C, Backhaus M, et al. Low-field MRI for assessing synovitis in patients with rheumatoid arthritis: impact of Gd-DTPA dose on synovitis scoring. Scand J Rheumatol 2006; 35: 27782.
  • 13
    Shellock FG, Spinazzi A. MRI safety update 2008: part I, MRI contrast agents and nephrogenic systemic fibrosis. AJR Am J Roentgenol 2008; 191: 112939.
  • 14
    Hetland ML, Ejbjerg B, Horslev-Petersen K, Jacobsen S, Vestergaard A, Jurik AG, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis: results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009; 68: 38490.
  • 15
    Hetland ML, Stengaard-Pederson K, Junker P, Ostergaard M, Ejbjerg BJ, Jacobsen S, et al, for the CIMESTRA Study Group. Radiographic progression and remission rates in early rheumatoid arthritis: MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial. Ann Rheum Dis 2010; 69: 278995.
  • 16
    Tamai M, Kawakami A, Uetani M, Takao S, Arima K, Iwamoto N, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum 2009; 61: 7728.
  • 17
    Symmons D, Tricker K, Harrison M, Roberts C, Davis M, Dawes P, et al. Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs: results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial. Rheumatology (Oxford) 2006; 45: 55865.
  • 18
    McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. What is the fate of erosions in early rheumatoid arthritis? Tracking individual lesions using x rays and magnetic resonance imaging over the first two years of disease. Ann Rheum Dis 2001; 60: 85968.
  • 19
    Dohn UM, Ejbjerg BJ, Court-Payen M, Hasselquist M, Narvestad E, Szkudlarek M, et al. Are bone erosions detected by magnetic resonance imaging and ultrasonography true erosions? A comparison with computed tomography in rheumatoid arthritis metacarpophalangeal joints. Arthritis Res Ther 2006; 8: R110.
  • 20
    Lindegaard HM, Vallo J, Horslev-Petersen K, Junker P, Ostergaard M. Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study. Ann Rheum Dis 2006; 65: 120812.
  • 21
    Parodi M, Silvestri E, Garlaschi G, Cimmino MA. How normal are the hands of normal controls? A study with dedicated magnetic resonance imaging. Clin Exp Rheumatol 2006; 24: 13441.
  • 22
    Xie X, Webber CE, Adachi J, O'Neill J, Inglis D, Bobba RS, et al. Quantitative, small bore, 1 Tesla, magnetic resonance imaging of the hands of patients with rheumatoid arthritis. Clin Exp Rheumatol 2008; 26: 8605.
  • 23
    Freeston JE, Wakefield RJ, Conaghan PG, Hensor E, Stewart SP, Emery P. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann Rheum Dis 2010; 69: 4179.
  • 24
    Brown AK, Quinn MA, Karim Z, Conaghan PG, Ikeda K, Peterfy CG, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug–induced clinical remission. Arthritis Rheum 2006; 54: 376173.
  • 25
    Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008; 58: 295867.